These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36335993)

  • 1. Reversible cerebral edema and herniation caused by 5-fluorouracil-induced hyperammonemic encephalopathy.
    Chiu YW; Tsui YK; Shen HN
    Am J Med Sci; 2023 Apr; 365(4):e63-e64. PubMed ID: 36335993
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluorouracil induced hyperammonemic encephalophathy: etiopathologic correlation.
    Martinez-Lapiscina EH; Erro ME; Cabada T; Tuñón T
    Can J Neurol Sci; 2012 Jul; 39(4):553-4. PubMed ID: 22896877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperammonemic encephalopathy in a patient treated with 5-fluorouracil].
    Barrueco N; Such Díaz A; Sáez de la Fuente J; Escobar I
    Farm Hosp; 2014 Jan; 38(1):77-8. PubMed ID: 24483867
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorouracil-induced Hyperammonemia in a Patient with Colorectal Cancer.
    Thomas SA; Tomeh N; Theard S
    Anticancer Res; 2015 Dec; 35(12):6761-3. PubMed ID: 26637893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.
    Verkerk K; Otten HM; Huitema ADR
    Cancer Chemother Pharmacol; 2022 Nov; 90(5):417-419. PubMed ID: 36127544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral Herniation from Hyperammonemic Cerebral Edema: A Potentially Reversible Neurological Emergency.
    Loggini A; Martinez RC; Kramer CL
    Neurocrit Care; 2019 Jun; 30(3):681-685. PubMed ID: 29998429
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.
    Fan CC; Huang MC; Liu HC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1747-8. PubMed ID: 18602440
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy.
    Boilève A; Wicker C; Verret B; Leroy F; Malka D; Jozwiak M; Pontoizeau C; Ottolenghi C; De Lonlay P; Ducreux M; Hollebecque A
    Anticancer Drugs; 2019 Mar; 30(3):313-317. PubMed ID: 30531368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemic Encephalopathy Associated with Perampanel: Case Report and Discussion.
    Marques PT; Zulfiqar Ali Q; Selvarajah A; Faghfoury H; Wennberg RA; Andrade DM
    Can J Neurol Sci; 2021 May; 48(3):438-439. PubMed ID: 32959734
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Advani PP; Fakih MG
    Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproate-induced hyperammonemic encephalopathy.
    Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
    Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity.
    Kim SR; Park CH; Park S; Park JO; Lee J; Lee SY
    Chemotherapy; 2010; 56(4):313-7. PubMed ID: 20714149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemic encephalopathy: a brief review.
    Lewis C; Deshpande A; Tesar GE; Dale R
    Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.